This site is intended for healthcare professionals only
LoginRegister
USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facilityStrides Pharma Science arm gets USFDA EIR for Alathur facility
PfizerSubmit diagnosis criteria for lower respiratory infection and earlier study data: CDSCO Panel Tells...
AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITCCDSCO Panel Approves AstraZeneca's protocol amendment proposal for COPD drug Tozorakimab
AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium CyclosilicateAstraZeneca gets USD 107 million Pfizer verdict overturned in US cancer drug patent fight
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibUSFDA grants marketing authorization for First To Know Syphilis Test for OTC use
TN Health invites applications for M Pharmacy admissions 2024, know all details hereTN Health invites applications for M Pharmacy admissions 2024, know all details here
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationIncrease sample size for immunogenicity analysis for booster dose: CDSCO Panel Tells Biological E on...
MSN Labs Gets CDSCO Panel Nod to Begin Phase III Trial of Cenobamate Tablets, With Safety CaveatMSN Laboratories gets CDSCO Panel nod to conduct Bioequivalence Study of Abiraterone Tablets1000mg
DCGI Told to Act Against Unapproved Antibiotic FDCsIndia's medicine, antibiotics exports gaining share in US, Italian markets: Govt
Shilpa Medicare Dabaspet unit gets VAI classification from USFDAANVISA-Brazil concludes inspection at Caplin Steriles Gummidipoondi facility with zero observations
Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatmentBristol Myers Squibb India Gets CDSCO Panel Nod to Study anticancer drug Mezigdomide
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibUSFDA grants accelerated approval to Gilead Sciences Livdelzi for Primary Biliary Cholangitis
X